{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:37:28Z","timestamp":1789706248103,"version":"4.0.1"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,26]],"date-time":"2012-12-26T00:00:00Z","timestamp":1356480000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0052753","type":"journal-article","created":{"date-parts":[[2012,12,26]],"date-time":"2012-12-26T22:10:13Z","timestamp":1356559813000},"page":"e52753","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["Vorinostat Eliminates Multicellular Resistance of Mesothelioma 3D Spheroids via Restoration of Noxa Expression"],"prefix":"10.1371","volume":"7","author":[{"given":"Dario","family":"Barbone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sailaja","family":"Battula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Busacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Longley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Sugarbaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean A.","family":"Fennell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Courtney","family":"Broaddus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,12,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1038\/cddis.2011.58","article-title":"The Bcl-2 repertoire of mesothelioma spheroids underlies acquired apoptotic multicellular resistance","volume":"2","author":"D Barbone","year":"2011","journal-title":"Cell Death Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1165\/rcmb.2007-0460OC","article-title":"mTOR mediates survival signals in malignant mesothelioma grown as tumor fragment spheroids","volume":"39","author":"SM Wilson","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1165\/rcmb.2008-0320OC","article-title":"Bcl-2 family proteins contribute to apoptotic resistance in lung cancer multicellular spheroids","volume":"41","author":"TM Yang","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1023\/B:APPT.0000038036.31271.50","article-title":"Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors","volume":"9","author":"F Facchetti","year":"2004","journal-title":"Apoptosis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/JTO.0b013e3181c5e366","article-title":"Histone deacetylase inhibitors in malignant pleural mesothelioma: preclinical rationale and clinical trials","volume":"5","author":"PK Paik","year":"2010","journal-title":"J Thorac Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.ejca.2011.11.009","article-title":"Vorinostat\/SAHA-induced apoptosis in malignant mesothelioma is FLIP\/caspase 8-dependent and HR23B-independent","volume":"48","author":"JL Hurwitz","year":"2012","journal-title":"Eur J Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/icb.2011.100","article-title":"HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications","volume":"90","author":"O Khan","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1182\/blood-2011-10-292003","article-title":"Histone\/protein deacetylases and T-cell immune responses","volume":"119","author":"T Akimova","year":"2012","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1097\/JTO.0b013e318260dfb9","article-title":"Phase II clinical trial of first or second-line treatment with bortezomib in patients with malignant pleural mesothelioma","volume":"7","author":"DA Fennell","year":"2012","journal-title":"J Thorac Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e14640","DOI":"10.1371\/journal.pone.0014640","article-title":"The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy","volume":"6","author":"X Xiang","year":"2011","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1039\/C0AN00609B","article-title":"High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array","volume":"136","author":"YC Tung","year":"2011","journal-title":"Analyst"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/cdd.2009.32","article-title":"Malignant pleural mesothelioma cells resist anoikis as quiescent pluricellular aggregates","volume":"16","author":"J Daubriac","year":"2009","journal-title":"Cell Death Differ"},{"key":"ref13","first-page":"2610","article-title":"p53 and Kirsten-ras mutations in human mesothelioma cell lines","volume":"52","author":"RA Metcalf","year":"1992","journal-title":"Cancer Res"},{"key":"ref14","first-page":"L165","article-title":"Resistance of pleural mesothelioma cell lines to apoptosis: relation to expression of Bcl-2 and Bax","volume":"275","author":"SR Narasimhan","year":"1998","journal-title":"Am J Physiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/0003-4975(94)90090-6","article-title":"Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma","volume":"57","author":"WR Smythe","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1165\/rcmb.2007-0205OC","article-title":"CaSm (LSm-1) overexpression in lung cancer and mesothelioma is required for transformed phenotypes","volume":"38","author":"PM Watson","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"13021","DOI":"10.1074\/jbc.M709698200","article-title":"Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids","volume":"283","author":"D Barbone","year":"2008","journal-title":"J Biol Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1165\/rcmb.2004-0355OC","article-title":"A novel in vitro model of human mesothelioma for studying tumor biology and apoptotic resistance","volume":"33","author":"KU Kim","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"NJ Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1038\/onc.2009.46","article-title":"Noxa: at the tip of the balance between life and death","volume":"27","author":"C Ploner","year":"2008","journal-title":"Oncogene"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1074\/jbc.M109.086231","article-title":"Perturbation of the Bcl-2 network and an induced Noxa\/Bcl-xL interaction trigger mitochondrial dysfunction after DNA damage","volume":"285","author":"H Lopez","year":"2010","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"17682","DOI":"10.1074\/jbc.M110.189092","article-title":"Noxa\/Bcl-2 protein interactions contribute to bortezomib resistance in human lymphoid cells","volume":"286","author":"AJ Smith","year":"2011","journal-title":"J Biol Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1158\/1078-0432.CCR-10-3412","article-title":"Vorinostat-induced apoptosis in mantle cell lymphoma is mediated by acetylation of proapoptotic BH3-only gene promoters","volume":"17","author":"S Xargay-Torrent","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1756-8722-2-31","article-title":"Vorinostat in solid and hematologic malignancies","volume":"2","author":"D Siegel","year":"2009","journal-title":"J Hematol Oncol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1183\/09031936.00037310","article-title":"Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II study","volume":"37","author":"A Scherpereel","year":"2011","journal-title":"Eur Respir J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.bcp.2011.11.010","article-title":"Sensitization of tumor cells by targeting histone deacetylases","volume":"83","author":"P Perego","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/1078-0432.CCR-11-1166","article-title":"Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737","volume":"18","author":"KM Lucas","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4155\/fmc.12.3","article-title":"Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed","volume":"4","author":"BE Gryder","year":"2012","journal-title":"Future Med Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0052753","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T05:16:52Z","timestamp":1540012612000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0052753"}},"subtitle":[],"editor":[{"given":"Keiran","family":"Smalley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,26]]},"references-count":29,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0052753","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,26]]}}}